Genetics and cholesterol metabolism

Current Opinion in Lipidology

Volumn 7, Issue 3, 1996, Pages 124-131

  Kesäniemi, Y Antero ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; COLON TUMOR; DIET; ENVIRONMENTAL FACTOR; GALLSTONE FORMATION; GENETIC REGULATION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; LIFESPAN; PRIORITY JOURNAL; REVIEW;

EID: 0030059132     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199606000-00003     Document Type: Review

References (80)

1. Genest JJ Jr, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, Wilson PWF, Salem DN, Schaefer EJ: Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992, 85:2025-2033.
2. Dammerman M, Breslow J: Genetic basis of lipoprotein disorders. Circulation 1995, 91:505-512. A recent thorough review of the genetic background of various lipoprotein abnormalities. In addition to the genetic and metabolic mechanisms, this review gives a good basis for future work on various clinical problems.
3. Brown MS, Goldstein JL: The hyperlipoproteinemlas and other disorders of lipid metabolism. In Harrison's principles of internal medicine. 12th ed. Edited by Wilson JD, Braunwals E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root R. New York: McGraw-Hill; 1991:1814-1825.
4. Goldstein JL, Brown MS: Familial hypercholesterolemia. In The metabolic basis of inherited disease. 6th ed. Edited by Scribner CR, Beaudet AL, Sly WS, Valle D. New York, NY: MacGraw-Hill; 1989;1215-1250.
5. Gylling H, Miettinen TA: Absorption and metabolism of cholesterol in familial hypercholesterolemia. Clin Sci 1989, 76:297-301.
6. Miettinen TA: Impact of apo E phenotype on the regulation of cholesterol metabolism. Ann Wed 1991, 23:181-186.
7. Miettinen TA: Cholesterol and bile acid synthesis In two families with homozygous and heterozygous hypercholesterolemia. Arteriosclerosis 1984, 4:383-388.
8. Zannis VI, Kardassis D, Zanni EE: Genetic mutations affecting human lipoproteins, their receptors, and their enzymes. In Advances in human genetics, vol. 21, Edited by Harris H, Hirschhorn K. New York, NY: Plenum Press; 1993:145-319.
9. Utermann GI, Kindermann I, Kaffarnik H, Steinmetz A: Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 1984, 65:232-236.
10. Tiret L, de Knijff P, Menzel H-J, Ehnholm C, Nicaud V, Havekes LM, on behalf of the EARS Group. ApoE polymorphism and predisposition to coronary heart disease In youths of different European populations. The EARS Study. Arterioscler Thromb 1994, 14:1617-1624.
11. Kao J-T, Tsai K-S, Chang C-J, Huang P-C: The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population. Atherosclerosis 1995, 114:55-59.
12. Kesäniemi YA, Miettinen TA: Metabolic epidemiology of plasma cholesterol. Ann Clin Res 1988, 20:26-31.
13. Gylling H, Kontula K, Miettinen TA: Cholesterol absorption and metabolism and LDL kinetics in healthy men with different apoprotein E phenotypes and apoprotein B Xba I and LDL receptor Pvu II genotypes. Arterioscler Thromb Vasc Biol 1995, 15:208-213.
14. Kesäniemi YA, Miettinen TA: Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest 1987, 17:391-395.
15. Miettinen TA, Kesäniemi YA: Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr 1989, 49:629-635.
16. Kesäniemi YA, Ehnholm C, Miettinen TA: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987, 80:578-581.
17. Weintraub MS, Eisenberg S, Breslow JL: Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987, 80:1571-1577.
18. Demant T, Houlston RS, Caslake MJ, Series JJ, Shepherd J. Packard CJ, Humpries SE: Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene. J Clin Invest 1988, 82:797-802.
19. Breslow JL: Familial disorders of high density lipoprotein metabolism. In The metabolic basis of inherited disease, 6th ed. Edited by Scrivner CR, Beaudet AL, Sly WS, Valle D. New York, NY: McGraw-Hill; 1989:1251-1266.
20. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport J Lipid Res 1995, 36:211-228. An excellant review of the various pathways of cholesterol transport from the peripheral tissues to the liver. This paper is a thorough discussion of the important proteins and molecular mechanisms, elucidating both in-vitro and in-vivo findings.
21. Kondo I, Berg K, Drayna D, Lawn R: DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989, 35:49-56.
22. Freeman DJ, Packard CJ, Shepherd J, Gaffney D: Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci 1990, 79:575-581.
23. Ukkola O, Savolainen MJ, Salmela PI, von Fickhoff K, Kesäniemi YA: DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus. Clin Genet 1994, 46:217-227.
24. Kauma H, Savolainen MJ, Heikkilä R, Rantala AO, Lilja M, Reunanen A, Kesäniemi YA: Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 1996, 97:156-162.
25. Savolainen MJ, Rantala M, Kervinen K, Järvi L, Suvanto K, Rantala T, Kesäniemi YA: Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype. Atherosclerosis 1991, 86:145-152.
26. Tikkanen MJ, Huttunen JK, Ehnholm C, Pietinen P: Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990, 10:285-288.
27. Mänttäri M, Koskinen P, Ehnholm C, Huttunen J, Manninen V: Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 1991, 40:217-221.
28. Miettinen TA, Gylling H, Vanhanen H, Ollus A: Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arteriöscler Thromb 1992, 12:1044-1052.
29. Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Cleridence B, Judd JT, Schaefer EJ: Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 1994, 35:1965-1975.
30. Dreon DM, Fernstrom HA, Miller B, Krauss RM: Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arterioscler Thromb Vase Biol 1995, 15:105-111.
31. Xu C-F, Boerwinkle E, Tikkanen MJ, Huttunen JK, Humpries SE, Talmud PJ: Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet Epidemiol 1990, 7:261-275.
32. Cobb MM, Teitlebaum H, Risch N, Jekel J, Ostfeld A: Influence of dietary fat apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation 1992, 86:857-859.
33. Sarkkinen ES, Uusitupa MU, Pietinen P, Aro A, Ahola I, Pentillä I, Kervinen K, Kesäniemi YA: Long-term effects of three fat-modified diets in hypercholesterolemic subjects. Atherosclerosis 1994, 105:9-23.
34. Zambon D, Ros E, Casals E, Sanllehy C, Bertomeu A, Campero I: Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia. Am J Clin Nutr 1995, 61:141-148.
35. Gylling H, Miettinen T: Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res 1992, 33: 1361-1371.
36. Lehtimäki T, Moilanen T, Solakivi T, Laippala P, Ehnholm C: Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Ann Med 1992, 24:61-66.
37. Glatz JFC, Demacker PNM, Turner PR, Katan MB: Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. Nutr Metab Cardiovasc Dis 1991, 1:13-17.
38. Boerwinkle E, Brown SA, Rohrback K, Gotto AM Jr, Patsch W: Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 1991, 49:1145-1154.
39. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, Quinet E, Tau AR, Marcel YL, McPherson R: Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 1993, 34:437-446.
40. Jones PJH, Main BF, Frohlich JJ: Response of cholesterol synthesis to cholesterol feeding in men with different apolipoprotein E genotypes. Metabolism 1993, 8:1065-1071.
41. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD: Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993. 71:160-165.
42. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Ruidavets JB, Cambien F, Fruchart JC, Ducimetiere P: Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb 1994, 14:1412-1419.
43. Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer BS, Allen A, Karagounis LA, Ward RH: Apolipoprotein polymorphisms fail to define risk of coronary artery disease: results of a prospective, angiographically controlled study. Circulation 1994, 89:567-577.
44. Hixson JE and the Pathological Determinants of Atherosclerosis in Youth (PDAY) Research Group: Apolipoprotein E polymorphism affects atherosclerosis in young males. Arterioscler Thromb 1991, 11:1237-1244.
45. Laakso M, Kesäniemi YA, Kervinen K, Jauhiainen M, Pyörälä K: Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin-dependent diabetes. BMJ 1991, 303:1159-1162.
46. Ukkola O, Kervinen K, Salmela PI, von Dickhoff K, Laakso M, Kesäniemi YA: Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 1993, 101:9-15.
47. Kuusisto J, Mykkänen L, Kervinen K, Kesäniemi YA, Laakso M: Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995, 15:1280-1286.
48. Stengård JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF: Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995, 91:265-269.
49. Boemi M, Sirolla C, Amadio L, Fumelli P, Pometta D, James RW Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care 1995, 18:504-508.
50. Valdez R, Howard BV, Stern MP, Haffner SM: Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care 1995, 18:992-1000. This paper shows that, in addition to the association with cholesterol levels, variability at the apoE locus may be associated with other metabolic factors such as insulinemia and insulin resistance.
51. Damaraju S, Yu Q-T, Safavi F, Marian AJ: Apolipoprotein E4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995, 75: 1181-1183.
52. Davignon J, Bouthillier D, Nestruck AC, Sing CF: Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Trans Am Clin Climatol Assoc 1987, 99:100-110.
53. Kervinen K, Savolainen MJ, Salokannel J, Hynninen A, Heikkinen J, Ehnholm C, Koistinen MJ, Kesäniemi YA: Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians. Atherosclerosis 1994, 105:89-95.
54. Louhija J, Miettinen HE, Kontula K, Tikkanen MJ, Miettinen TA, Tilvis RS: Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler Thromb 1994, 14:1084-1089.
55. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 and risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
56. Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, Pyörälä K, Kesäniemi YA, Riekkinen P, Laakso M: Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 1994, 309:636-638.
57. Gylling H, Strandberg T, Tilvis R, Miettinen TA: Regulation of serum cholesterol level in middle-aged and elderly men. Arterioscler Thromb 1994, 14:694-700. A detailed mechanistic study of the overall regulation of cholesterol metabolism providing novel information on older individuals.
58. Sutor DJ, Wooley SE: A statistical survey of the composition of gallstones in eight countries. Gut 1971, 12:55-64.
59. Danzinger GR, Gordon H, Schoenfield LJ, Thistle JL: Lithogenic bile in siblings of young women with cholelithiasis. Mayo Clin Proc 1972, 47:762-766.
60. Kesäniemi YA, Koskenvuo M, Vuoristo M, Miettinen TA: Biliary lipid composition in monozygotic and dizygotic pairs of twins. Gut 1989, 30:1750-1756.
61. Vlahcevic ZR, Bell CC Jr, Buhac I, Farrar JT, Swell L: Diminished bile acid pool size in patients with gallstones. Gastroenterology 1970, 59:165-173.
62. Grundy SM, Metzger AL, Adler RD: Mechanism of lithogenic bile formation in American Indian women with cholesterol gallstones. J Clin Invest 1972, 51:3026-3043.
63. Sedaghat A, Grundy SM: Cholesterol crystals and the formation of cholesterol gallstones N Engl J Med 1980, 302:1274-1277.
64. Juvonen T, Kervinen K, Kairaluoma MI, Lajunen LHJ, Kesäniemi YA: Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993, 104:1806-1813.
65. Juvonen T, Savolainen MJ, Kairaluoma MI, Lajunen LHJ, Humpries SE, Kesäniemi YA: Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res 1995, 36:804-812.
66. Thijs C, Knipschild P, Brombacher P: Serum lipids and galtstones: a casecontrol study. Gastroenterology 1990, 99:843-849.
67. Busch N, Tokumo H, Holzbach RT: Sensitive method for determination of cholesterol crystal growth using model solutions of supersaturated bile. J Lipid Res 1990, 31:1903-1909.
68. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993, 329:1977-1981.
69. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin J-P, Järvinen H, Powell S, Jin J, Hamilton SR, et al.: Clues to the pathogenesis of familial colorectal cancer. Science 1993, 260:812-816.
70. Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG. Burt RW: Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancer. N Engl J Med 1988, 319:533-537.
71. Kervinen K, Södervik H, Mäkelä J, Lehtola J, Niemi M, Kairaluoma MI, Kesäniemi YA: Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology. 1996 (In press). A new study which links the genetic regulation of cholesterol metabolism with intestinal tumor formation.
72. Sandler RS, Lyles CM, Peipins LA, McAuliffe CA, Woosley JT, Kupper LL: Diet and risk of colorectal adenomas: macronutrients, cholesterol and fiber. J Natl Cancer Inst 1993, 85:884-891.
73. Reddy BS, Wynder EL: Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer 1977, 39:2533-2539.
74. Bayerdörffer E, Mannes GA, Richter WO, Ochsenkuhn T, Wiebecke B, Köpcke W, Baumgartner G: Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology 1993, 104:145-151.
75. Vogel T, Guo N-H, Guy R, Drezlich N, Krutzsch HC, Blake DA, Panet A, Roberts DD: Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem 1994, 54:299-308. An interesting paper demonstrating that apoE is a potent inhibitor of proliferation of several cell types This suggests that apoE may be effective in modulating angiogenesis, tumor cell growth and metastasis.
76. Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
77. Kark JD, Smith AH, Hames CG: The relationship of serum cholesterol to the incidence of cancer in Evans county, Georgia. J Chron Dis 1980, 33:311-322.
78. Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR: Cancer incidence by levels of cholesterol. JAMA 1981, 245:247-252.
79. O'Rourke JS, Johnson A, Collins P, Duignan J, Bouchier-Hayes D: An association between hypocholesterolaemia and colorectal carcinoma in an Irish population. Gut 1992, 33:950-953.
80. Mannes GA, Maier A, Thieme C, Wiebecke B, Paumgartner G: Relation between the frequency of colorectal adenoma and the serum cholesterol level. N Engl J Med 1986, 315:1634-1648.